14th Annual PEGS Boston
Date: April 30 - May 4, 2018
Venue: Seaport World Trade Center, Boston, Massachusetts USA

PEGS: The Essential Protein Engineering Summit is one of the industry's most preeminent events that inspires accelerated biotherapeutic protein drug development. This weeklong event attracts over 2,300 international participants, and features nearly 400 presentations by world renowned leaders from pharma, academia, and government showcasing case studies, cutting edge data, insight and perspective. Conference programs include a broad spectrum of topics including protein and antibody engineering, cancer immunotherapy, oncology, and emerging therapeutics.


PLENARY KEYNOTES

WittrupChallenges and Opportunities in Engineering Protein Biopharmaceuticals  

K. Dane Wittrup, PhD,

C.P. Dubbs Professor, Chemical Engineering and Biological Engineering; Associate Director, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT)

Kipp WeiskopfYOUNG SCIENTIST KEYNOTE
The Next Generation of Cancer Immunotherapy: Targeting Myeloid Immune Checkpoints
 

Kipp Weiskopf, MD, PhD,

Resident Physician, Internal Medicine, Brigham and Women's Hospital



EVENT FEATURES

 

  • 2,300 Participants from around the World
  • 22 Conferences, Plus! Training Seminars and Short Courses
  • More than 350 Scientific Presentations
  • Nearly 200 Research Posters
  • Interactive Roundtables, Breakouts & Panel Discussions
  • Dedicated Exhibit & Poster Viewing Hours
  • Exclusive Networking Opportunities

 


 

TESTIMONIALS

"I thought the conference was well organized, as usual, but particularly in regard to the breadth of topics covered and the connections made between disciplines was nice to see - very forward looking."
Research Scientist, AbbVie

"The talks were all very high quality and the networking opportunities and round-tables last night were very good too."
Director, United States Pharmacopeial Convention

"I had a great set of interactions with folks at the meeting, and glad to see the programs and attendance remain very strong."
Professor, University of Delaware